- Report
- December 2024
- 438 Pages
Global
From €3521EUR$4,000USD£3,044GBP
- Report
- June 2023
- 75 Pages
Europe
From €3517EUR$3,995USD£3,040GBP
- Report
- March 2025
- 96 Pages
Global
From €3500EUR$4,259USD£3,131GBP
- Report
- March 2025
- 110 Pages
Global
From €3500EUR$4,259USD£3,131GBP
- Report
- January 2025
- 89 Pages
Global
From €3500EUR$4,259USD£3,131GBP
- Report
- April 2024
- 106 Pages
Asia Pacific
From €3037EUR$3,450USD£2,625GBP
- Report
- April 2024
- 96 Pages
North America
From €3037EUR$3,450USD£2,625GBP
- Report
- January 2023
- 145 Pages
Europe
From €3037EUR$3,450USD£2,625GBP
- Report
- January 2023
- 140 Pages
Africa, Middle East
From €3037EUR$3,450USD£2,625GBP
- Report
- October 2023
- 450 Pages
Global
From €1100EUR$1,250USD£951GBP
€2201EUR$2,500USD£1,902GBP
- Report
- October 2023
- 100 Pages
Africa
From €1761EUR$2,000USD£1,522GBP
- Report
- October 2023
- 80 Pages
United States
From €1321EUR$1,500USD£1,141GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1321EUR$1,500USD£1,141GBP
From €1321EUR$1,500USD£1,141GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1321EUR$1,500USD£1,141GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1321EUR$1,500USD£1,141GBP
- Report
- October 2023
- 80 Pages
India
From €1321EUR$1,500USD£1,141GBP
- Report
- October 2023
- 80 Pages
Germany
From €1321EUR$1,500USD£1,141GBP
- Report
- October 2023
- 80 Pages
France
From €1321EUR$1,500USD£1,141GBP
- Report
- October 2023
- 80 Pages
China
From €1321EUR$1,500USD£1,141GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more